Crit Care

• 

  Publication Venue For

  • Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring..  24:364. 2020
  • The unique characteristics of COVID-19 coagulopathy..  24:360. 2020
  • Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2..  24:182. 2020
  • Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO..  24:19. 2020
  • Nutrition therapy and critical illness: practical guidance for the ICU, post-ICU, and long-term convalescence phases..  23:368. 2019
  • Metabolic support in the critically ill: a consensus of 19..  23:318. 2019
  • Recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy (SCARLET): an updated meta-analysis..  23:302. 2019
  • Thrombomodulin in disseminated intravascular coagulation and other critical conditions-a multi-faceted anticoagulant protein with therapeutic potential..  23:280. 2019
  • Microcirculatory perfusion disturbances in septic shock: results from the ProCESS trial..  22:308. 2018
  • Bacterial contamination of platelets for transfusion: strategies for prevention..  22:271. 2018
  • Seven unconfirmed ideas to improve future ICU practice..  21:315. 2017
  • Tailoring nutrition therapy to illness and recovery..  21:316. 2017
  • A randomized trial of supplemental parenteral nutrition in underweight and overweight critically ill patients: the TOP-UP pilot trial..  21:142. 2017
  • Erratum to: Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis..  21:42. 2017
  • Response to "Reassessing the death risk related to probiotics in critically ill patients"..  21:43. 2017
  • Predicting critical illness mortality and personalizing therapy: moving to multi-dimensional data..  21:20. 2017
  • Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal..  20:273. 2016
  • Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis..  19:262. 2016
  • Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation..  20:115. 2016
  • Sepsis 2016 Agra, India. Agra, India. 5-6 February 2016..  20 Suppl 1:45. 2016
  • Discordant identification of pediatric severe sepsis by research and clinical definitions in the SPROUT international point prevalence study..  19:325. 2015
  • Clinical impact of stress dose steroids in patients with septic shock: insights from the PROWESS-Shock trial..  19:193. 2015
  • Metabolic and nutritional support of critically ill patients: consensus and controversies..  19:35. 2015
  • A few of our favorite unconfirmed ideas..  19 Suppl 3:S1. 2015
  • Winning the war against ICU-acquired weakness: new innovations in nutrition and exercise physiology..  19 Suppl 3:S6. 2015
  • Clinical relevance of procalcitonin and C-reactive protein as infection markers in renal impairment: a cross-sectional study..  18:640. 2014
  • The ProVent model learns to speak French..  18:576. 2014
  • Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients..  18:R163. 2014
  • Parenteral glutamine supplementation in critical illness: a systematic review..  18:R76. 2014
  • Should hydroxyethyl starch solutions be totally banned?.  17:193. 2013
  • Development and standardization of a furosemide stress test to predict the severity of acute kidney injury..  17:R207. 2013
  • Early propranolol treatment induces lung heme-oxygenase-1, attenuates metabolic dysfunction, and improves survival following experimental sepsis..  17:R195. 2013
  • Does artificial nutrition improve outcome of critical illness? An alternative viewpoint!.  17:324. 2013
  • Patient-ventilator trigger dys-synchrony: a common phenomenon with important implications..  17:157. 2013
  • Algorithm-based management of bleeding in patients with extracorporeal membrane oxygenation..  17:432. 2013
  • Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury..  17:R25. 2013
  • Our favorite unproven ideas for future critical care..  17 Suppl 1:S9. 2013
  • The evolution of nutrition in critical care: how much, how soon?.  17 Suppl 1:S7. 2013
  • Misleading indexed hemodynamic parameters: the clinical importance of discordant BMI and BSA at extremes of weight..  16:471. 2012
  • The host response to infection: advancing a novel diagnostic paradigm..  16:168. 2012
  • Indexed hemodynamic measurements may be inappropriate at body surface area extremes..  16:149. 2012
  • Measurement of multiple biomarkers in advanced stage heart failure patients treated with pulmonary artery catheter guided therapy..  16:R135. 2012
  • Association of gender with outcomes in critically ill patients..  16:R92. 2012
  • Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice..  15:R153. 2011
  • Bench-to-bedside review: sepsis - from the redox point of view..  15:230. 2011
  • Clinical review: Optimizing enteral nutrition for critically ill patients--a simple data-driven formula..  15:234. 2011
  • Clinical review: oxygen as a signaling molecule..  14:234. 2010
  • Goal-directed or goal-misdirected - how should we interpret the literature?.  14:129. 2010
  • The impact of IL-1 modulation on the development of lipopolysaccharide-induced cognitive dysfunction..  14:R88. 2010
  • Clinical review: checklists - translating evidence into practice..  13:210. 2009
  • Neuroimmune perspectives in sepsis..  13:133. 2009
  • Differences in one-year health outcomes and resource utilization by definition of prolonged mechanical ventilation: a prospective cohort study..  11:R9. 2007
  • Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: a prospective cohort study..  10:R37. 2006
  • Updates in the perioperative and emergency management of non-vitamin K antagonist oral anticoagulants..  19:203. 2015